Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Vascular endothelial growth factor (VEGF) is a regulator of vasculogenesis and angiogenesis. To investigate the role of nitric oxide (NO) in VEGF-induced proliferation and in vitro angiogenesis, human umbilical vein endothelial cells (HUVEC) were used. VEGF stimulated the growth of HUVEC in an NO-dependent manner. In addition, VEGF promoted the NO-dependent formation of network-like structures in HUVEC cultured in three dimensional (3D) collagen gels. Exposure of cells to VEGF led to a concentration-dependent increase in cGMP levels, an indicator of NO production, that was inhibited by nitro-L-arginine methyl ester. VEGF-stimulated NO production required activation of tyrosine kinases and increases in intracellular calcium, since tyrosine kinase inhibitors and calcium chelators attenuated VEGF-induced NO release. Moreover, two chemically distinct phosphoinositide 3 kinase (PI-3K) inhibitors attenuated NO release after VEGF stimulation. In addition, HUVEC incubated with VEGF for 24 h showed an increase in the amount of endothelial NO synthase (eNOS) protein and the release of NO. In summary, both short- and long-term exposure of human EC to VEGF stimulates the release of biologically active NO. While long-term exposure increases eNOS protein levels, short-term stimulation with VEGF promotes NO release through mechanisms involving tyrosine and PI-3K kinases, suggesting that NO mediates aspects of VEGF signaling required for EC proliferation and organization in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Inositol phosphates and cell signalling
Berridge, M. J., & Irvine, R. F. (1989) · Nature · doi:10.1038/341197a0 · Cited by 4,058
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Cited by
Items 101–137 of 137
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis.
Kimura, H., & Esumi, H. (2003) · Acta Biochimica Polonica · doi:10.18388/abp.2003_3713 · Cited by 258
Resveratrol in Cardioprotection: A Therapeutic Promise of Alternative Medicine
Das, D. K. (2006) · Molecular Interventions · doi:10.1124/mi.6.1.7 · Cited by 258
Kapil, V., Khambata, R. S., Jones, D. A., Rathod, K., Primus, C., Massimo, G., Fukuto, J. M., & Ahluwalia, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019240 · Cited by 248
Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension
Hampl, V., & Herget, J. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1337 · Cited by 248
“It can alter or mediate the response of cultured vascular smooth muscle or endothelium to various growth factors (273, 274, 345), although a lack of such an effect has also been reported (34).”
Potential application of gaseous nitric oxide as a topical antimicrobial agent
Ghaffari, A., Miller, C. C., McMullin, B., & Ghahary, A. (2006) · Nitric Oxide · doi:10.1016/j.niox.2005.08.003 · Cited by 236
Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47
Kaur, S., Martin-Manso, G., Pendrak, M. L., Garfield, S. H., Isenberg, J. S., & Roberts, D. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172304 · Cited by 235
Tetrahydrobiopterin in Cardiovascular Health and Disease
Bendall, J. K., Douglas, G., McNeill, E., Channon, K. M., & Crabtree, M. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5566 · Cited by 231
“eNOS and NO have been shown to mediate VEGF-induced endothelial cell proliferation (153, 200) and angiogenesis (185, 200) and to play a critical role in the prevention of endothelial cell senescence (196, 279) and apoptosis (58, 131, 224, 322).”
Kim, Y.-M., Pae, H.-O., Park, J. E., Lee, Y. C., Woo, J. M., Kim, N.-H., Choi, Y. K., Lee, B.-S., Kim, S. R., & Chung, H.-T. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3153 · Cited by 224
“VEGF is also able to stimulate HO-1 expression (35) and eNOS-derived NO production (204) in ECs, consequently inducing angiogenesis (Fig.”
Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation
Sayed, N., Baskaran, P., Ma, X., van den Akker, F., & Beuve, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703944104 · Cited by 221
Sonveaux, P., Martinive, P., DeWever, J., Batova, Z., Daneau, G., Pelat, M., Ghisdal, P., Grégoire, V., Dessy, C., Balligand, J.-L., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000136344.27825.72 · Cited by 220
Hydrogen sulphide and angiogenesis: mechanisms and applications
Szabó, C., & Papapetropoulos, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01191.x · Cited by 217
“The dependence of VEGF signalling on H2S might be due to the fact that VEGF increases intracellular calcium levels (Papapetropoulos et al., 1997) that will, in turn, promote a calmodulin-dependent increase in CSE activity (Yang et al., 2008).”
BackgroundSelf-citationNerve growth factor control of neuronal expression of angiogenetic and vasoactive factors
Calzà, L., Giardino, L., Giuliani, A., Aloe, L., & Levi-Montalcini, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626998 · Cited by 215
Yue, P. Y. K., Mak, N. K., Cheng, Y. K., Leung, K. W., Ng, T. B., Fan, D. T. P., Yeung, H. W., & Wong, R. N. S. (2007) · Chinese Medicine · doi:10.1186/1749-8546-2-6 · Cited by 211
“Page 15 of 21 (page number not for citation purposes) LAMA4: Laminin-α4 LDL: Low-density-lipoprotein L-NAME: Nω-nitro-L-arginine methylester MDR: Multi-drug resistance MMPs: Matrix metalloproteinases MR: Mineralocorticoid receptor MVD: Microvessel density MX: Mitoxantrone OH: Hydroxyl PA: Plasminogen activators PAI-1:…”
Dessy, C., Saliez, J., Ghisdal, P., Daneau, G., Lobysheva, I. I., Frérart, F., Belge, C., Jnaoui, K., Noirhomme, P., Feron, O., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.532960 · Cited by 210
Angiogenesis, vascular endothelial growth factor and the endometrium
Smith, S. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.509 · Cited by 209
“VEGF stimulates nitric oxide release from endothelial cells (Papapetropoulos et al., 1997) and induces hypotension in rabbits and pigs (Horowitz et al., 1997).”
BackgroundThe Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics
Divakaran, S., & Loscalzo, J. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1064 · Cited by 204
Armesilla, A. L., Lorenzo, E., Gómez del Arco, P., Martínez-Martínez, S., Alfranca, A., & Redondo, J. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2032 · Cited by 198
“In accordance with a functional activation of phospholipase Cg, VEGF has also been reported to induce turnover of inositol phosphates, diacylglycerol production, and elevation of intracellular Ca(21) concentrations (3, 45, 67).”
BackgroundLal, B. K., Varma, S., Pappas, P. J., Hobson, R. W., & Durán, W. N. (2001) · Microvascular Research · doi:10.1006/mvre.2001.2338 · Cited by 197
Kashiwagi, S., Izumi, Y., Gohongi, T., Demou, Z. N., Xu, L., Huang, P. L., Buerk, D. G., Munn, L. L., Jain, R. K., & Fukumura, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24015 · Cited by 188
“NO has been shown to mediate cell migration and proliferation as well as tube formation and survival of endothelial cells in vitro (33, 44).”
BackgroundChronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis
Kumar, D., Branch, B. G., Pattillo, C. B., Hood, J., Thoma, S., Simpson, S., Illum, S., Arora, N., Chidlow, J. H., Langston, W., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711480105 · Cited by 187
Limbourg, F. P., Huang, Z., Plumier, J.-C., Simoncini, T., Fujioka, M., Tuckermann, J., Schütz, G., Moskowitz, M. A., & Liao, J. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15481 · Cited by 187
“For measurement of intracellular cGMP (26), cells were pretreated with 0.”
Molecular control of nitric oxide synthases in the cardiovascular system
Papapetropoulos, A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00161-3 · Cited by 185
Self-citationeNOS phosphorylation in health and disease
Kolluru, G. K., Siamwala, J. H., & Chatterjee, S. (2010) · Biochimie · doi:10.1016/j.biochi.2010.03.020 · Cited by 183
Endothelial NOS: perspective and recent developments
Garcia, V., & Sessa, W. C. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14522 · Cited by 181
“Some additional stimuli that induce eNOS include VEGF-A (Papapetropoulos et al., 1997; Bouloumie et al., 1999), TGFβ (Saura et al., 2002), lysophosphotidycholine (Zembowicz et al., 1995), statins (Laufs et al., 1998), cyclosporine A (Navarro-Antolin et al., 2000), H202 (Searles, 2006), and…”
BackgroundSelf-citationHuang, D., Sun, L., Huang, L., & Chen, Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020124 · Cited by 176
Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis
Bauer, P. M., Yu, J., Chen, Y., Hickey, R., Bernatchez, P. N., Looft-Wilson, R., Huang, Y., Giordano, F., Stan, R. V., & Sessa, W. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406092102 · Cited by 168
Self-citationYoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22322 · Cited by 165
“ADI inhibited the production of nitric oxide (NO) by nitric oxide synthase (NOS) through the modulation of extracellular level of arginine,(5,32,33) and NO plays a role in angiogenesis because it could modulate the activity of vascular endothelial growth factor, basic fibroblast growth factor and matrix metalloprotein…”
BackgroundAngiostatin Inhibits Coronary Angiogenesis During Impaired Production of Nitric Oxide
Matsunaga, T., Weihrauch, D. W., Moniz, M. C., Tessmer, J., Warltier, D. C., & Chilian, W. M. (2002) · Circulation · doi:10.1161/01.cir.0000015856.84385.e9 · Cited by 163
Anti-cancer effect of Annona Muricata Linn Leaves Crude Extract (AMCE) on breast cancer cell line
Syed Najmuddin, S. U. F., Romli, M. F., Hamid, M., Alitheen, N. B., & Nik Abd Rahman, N. M. A. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1290-y · Cited by 160
“Persistent expression of this mutagenic NO could contribute to tumor growth, metastasis, and angiogenesis as indicated in previous studies [45, 46].”
ResultActivation of Endothelial Nitric-oxide Synthase by the p38 MAPK in Response to Black Tea Polyphenols
Anter, E., Thomas, S. R., Schulz, E., Shapira, O. M., Vita, J. A., & Keaney, J. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405547200 · Cited by 142
The role of kinin receptors in cancer and therapeutic opportunities
da Costa, P. L. N., Sirois, P., Tannock, I. F., & Chammas, R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.009 · Cited by 133
“009 vascular permeability [109,124].”
Husmann, F., Bruhn, S., Mittlmeier, T., Zschorlich, V., & Behrens, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00404 · Cited by 77
Clinical translation of nitrite therapy for cardiovascular diseases
Calvert, J. W., & Lefer, D. J. (2010) · Nitric Oxide · doi:10.1016/j.niox.2009.11.001 · Cited by 72
“NO has been reported to play a role in mediating vascular endothelial growth factor (VEGF)-mediated angiogenesis [81,82], suggesting that NO donor therapy would be very beneficial for therapeutic angiogenesis.”
BackgroundBueno, M., Wang, J., Mora, A. L., & Gladwin, M. T. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4833 · Cited by 68
Induction of angiogenesis by murine resistin: putative role of PI3-kinase and NO-dependent pathways
Robertson, S. A., Rae, C. J., & Graham, A. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2008.07.008 · Cited by 35
Dhananjayan, K., Gunawardena, D., Hearn, N., Sonntag, T., Moran, C., Gyengesi, E., Srikanth, V., & Münch, G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161152 · Cited by 24
Effects of long term nitrite therapy on functional recovery in experimental ischemia model
Jung, K.-H., Chu, K., Lee, S.-T., Sunwoo, J.-S., Park, D.-K., Kim, J.-H., Kim, S., Lee, S. K., Kim, M., & Roh, J.-K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.116 · Cited by 23
Metadata
- Authors
- Papapetropoulos, A., García-Cardeña, G., Madri, J. A., & Sessa, W. C.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-12-15
- Volume
- 100
- Issue
- 12
- Pages
- 3131-3139
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2041034845
- Cited by
- 1,191
- References
- 64
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.